292 related articles for article (PubMed ID: 34722339)
1.
Ahamefule CS; Ezeuduji BC; Ogbonna JC; Moneke AN; Ike AC; Jin C; Wang B; Fang W
Front Cell Infect Microbiol; 2021; 11():751947. PubMed ID: 34722339
[TBL] [Abstract][Full Text] [Related]
2.
Ahamefule CS; Qin Q; Odiba AS; Li S; Moneke AN; Ogbonna JC; Jin C; Wang B; Fang W
Front Cell Infect Microbiol; 2020; 10():320. PubMed ID: 32670897
[No Abstract] [Full Text] [Related]
3. Caenorhabditis elegans as a model animal for investigating fungal pathogenesis.
Madende M; Albertyn J; Sebolai O; Pohl CH
Med Microbiol Immunol; 2020 Feb; 209(1):1-13. PubMed ID: 31555911
[TBL] [Abstract][Full Text] [Related]
4. Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffei.
Huang X; Li D; Xi L; Mylonakis E
PLoS One; 2014; 9(9):e108764. PubMed ID: 25268236
[TBL] [Abstract][Full Text] [Related]
5. Caenorhabditis elegans-based model systems for antifungal drug discovery.
Anastassopoulou CG; Fuchs BB; Mylonakis E
Curr Pharm Des; 2011; 17(13):1225-33. PubMed ID: 21470110
[TBL] [Abstract][Full Text] [Related]
6. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
7. Filamentous Fungi.
Powers-Fletcher MV; Kendall BA; Griffin AT; Hanson KE
Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337469
[TBL] [Abstract][Full Text] [Related]
8. Caenorhabditis elegans: a nematode infection model for pathogenic fungi.
Muhammed M; Coleman JJ; Mylonakis E
Methods Mol Biol; 2012; 845():447-54. PubMed ID: 22328394
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of microbial secondary metabolites.
Coleman JJ; Ghosh S; Okoli I; Mylonakis E
PLoS One; 2011; 6(9):e25321. PubMed ID: 21966496
[TBL] [Abstract][Full Text] [Related]
10. Whole animal HTS of small molecules for antifungal compounds.
Muhammed M; Arvanitis M; Mylonakis E
Expert Opin Drug Discov; 2016; 11(2):177-84. PubMed ID: 26593386
[TBL] [Abstract][Full Text] [Related]
11. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
Gehrt A; Peter J; Pizzo PA; Walsh TJ
J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745
[TBL] [Abstract][Full Text] [Related]
12. Antifungal chemical compounds identified using a C. elegans pathogenicity assay.
Breger J; Fuchs BB; Aperis G; Moy TI; Ausubel FM; Mylonakis E
PLoS Pathog; 2007 Feb; 3(2):e18. PubMed ID: 17274686
[TBL] [Abstract][Full Text] [Related]
13. Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.
Blumental S; Mouy R; Mahlaoui N; Bougnoux ME; Debré M; Beauté J; Lortholary O; Blanche S; Fischer A
Clin Infect Dis; 2011 Dec; 53(12):e159-69. PubMed ID: 22080130
[TBL] [Abstract][Full Text] [Related]
14. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
[TBL] [Abstract][Full Text] [Related]
15. Juxtaposing Caenorhabditis elegans-Pathogenic Mould Model with Other Models; How Reliable Is This Nematode Model? A Mini Review.
Ahamefule CS; Ahamefule BC; Ike AC; Ogbonna JC; Moneke AN
Curr Microbiol; 2023 Feb; 80(4):105. PubMed ID: 36790616
[TBL] [Abstract][Full Text] [Related]
16. Models of Caenorhabditis elegans infection by bacterial and fungal pathogens.
Powell JR; Ausubel FM
Methods Mol Biol; 2008; 415():403-27. PubMed ID: 18370168
[TBL] [Abstract][Full Text] [Related]
17. Characteristics, Clinical Relevance, and the Role of Echinocandins in Fungal-Bacterial Interactions.
Arvanitis M; Mylonakis E
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S630-4. PubMed ID: 26567281
[TBL] [Abstract][Full Text] [Related]
18. Antifungal drug discovery through the study of invertebrate model hosts.
Pukkila-Worley R; Holson E; Wagner F; Mylonakis E
Curr Med Chem; 2009; 16(13):1588-95. PubMed ID: 19442135
[TBL] [Abstract][Full Text] [Related]
19. Invertebrate models of fungal infection.
Arvanitis M; Glavis-Bloom J; Mylonakis E
Biochim Biophys Acta; 2013 Sep; 1832(9):1378-83. PubMed ID: 23517918
[TBL] [Abstract][Full Text] [Related]
20. Central Role of the Trehalose Biosynthesis Pathway in the Pathogenesis of Human Fungal Infections: Opportunities and Challenges for Therapeutic Development.
Thammahong A; Puttikamonkul S; Perfect JR; Brennan RG; Cramer RA
Microbiol Mol Biol Rev; 2017 Jun; 81(2):. PubMed ID: 28298477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
